DARZALEX® (daratumumab) Phase 3 data and Janssen Immuno-Oncology Strategy Webcast

Source: Johnson and Johnson Podcasts - July 7, 2016 Category: Pharmaceuticals Source Type: podcasts

More News: Cancer & Oncology | Pharmaceuticals | Podcasts